GB2118482A - Pulp fiber structure - Google Patents
Pulp fiber structure Download PDFInfo
- Publication number
- GB2118482A GB2118482A GB08211191A GB8211191A GB2118482A GB 2118482 A GB2118482 A GB 2118482A GB 08211191 A GB08211191 A GB 08211191A GB 8211191 A GB8211191 A GB 8211191A GB 2118482 A GB2118482 A GB 2118482A
- Authority
- GB
- United Kingdom
- Prior art keywords
- skin layer
- pile
- blood
- pulp fibers
- pulp
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000835 fiber Substances 0.000 title claims abstract description 46
- 238000001816 cooling Methods 0.000 claims abstract description 35
- 239000000659 freezing mixture Substances 0.000 claims abstract description 13
- 229940030225 antihemorrhagics Drugs 0.000 claims abstract description 10
- 238000001035 drying Methods 0.000 claims abstract description 5
- 238000003825 pressing Methods 0.000 claims abstract description 5
- 229920001131 Pulp (paper) Polymers 0.000 claims abstract description 4
- 238000009736 wetting Methods 0.000 claims abstract description 3
- 239000002874 hemostatic agent Substances 0.000 claims description 9
- 239000002131 composite material Substances 0.000 abstract 1
- 210000004369 blood Anatomy 0.000 description 30
- 239000008280 blood Substances 0.000 description 30
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 30
- 208000027418 Wounds and injury Diseases 0.000 description 25
- 229920006395 saturated elastomer Polymers 0.000 description 12
- 230000006378 damage Effects 0.000 description 11
- 230000000694 effects Effects 0.000 description 10
- 206010039509 Scab Diseases 0.000 description 9
- 210000002966 serum Anatomy 0.000 description 9
- 208000014674 injury Diseases 0.000 description 8
- 230000009471 action Effects 0.000 description 7
- 230000015271 coagulation Effects 0.000 description 7
- 238000005345 coagulation Methods 0.000 description 7
- 208000010040 Sprains and Strains Diseases 0.000 description 5
- 239000007788 liquid Substances 0.000 description 5
- 206010024453 Ligament sprain Diseases 0.000 description 4
- 239000002390 adhesive tape Substances 0.000 description 4
- 239000000203 mixture Substances 0.000 description 4
- 230000000717 retained effect Effects 0.000 description 4
- 102000009123 Fibrin Human genes 0.000 description 3
- 108010073385 Fibrin Proteins 0.000 description 3
- BWGVNKXGVNDBDI-UHFFFAOYSA-N Fibrin monomer Chemical compound CNC(=O)CNC(=O)CN BWGVNKXGVNDBDI-UHFFFAOYSA-N 0.000 description 3
- 230000000740 bleeding effect Effects 0.000 description 3
- 230000017531 blood circulation Effects 0.000 description 3
- 238000004090 dissolution Methods 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 239000004744 fabric Substances 0.000 description 3
- 229950003499 fibrin Drugs 0.000 description 3
- 239000012466 permeate Substances 0.000 description 3
- 210000002381 plasma Anatomy 0.000 description 3
- 230000007480 spreading Effects 0.000 description 3
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- 206010015866 Extravasation Diseases 0.000 description 2
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 2
- 208000007536 Thrombosis Diseases 0.000 description 2
- 239000000853 adhesive Substances 0.000 description 2
- 230000001070 adhesive effect Effects 0.000 description 2
- 210000000601 blood cell Anatomy 0.000 description 2
- 230000036251 extravasation Effects 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000011505 plaster Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000002459 sustained effect Effects 0.000 description 2
- 230000008961 swelling Effects 0.000 description 2
- XQJMXPAEFMWDOZ-UHFFFAOYSA-N 3exo-benzoyloxy-tropane Natural products CN1C(C2)CCC1CC2OC(=O)C1=CC=CC=C1 XQJMXPAEFMWDOZ-UHFFFAOYSA-N 0.000 description 1
- 102000008946 Fibrinogen Human genes 0.000 description 1
- 108010049003 Fibrinogen Proteins 0.000 description 1
- QQXLDOJGLXJCSE-UHFFFAOYSA-N N-methylnortropinone Natural products C1C(=O)CC2CCC1N2C QQXLDOJGLXJCSE-UHFFFAOYSA-N 0.000 description 1
- 206010033799 Paralysis Diseases 0.000 description 1
- QIZDQFOVGFDBKW-DHBOJHSNSA-N Pseudotropine Natural products OC1C[C@@H]2[N+](C)[C@H](C1)CC2 QIZDQFOVGFDBKW-DHBOJHSNSA-N 0.000 description 1
- 206010039203 Road traffic accident Diseases 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 230000002421 anti-septic effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000008859 change Effects 0.000 description 1
- 239000003795 chemical substances by application Substances 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 238000010586 diagram Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 229940012952 fibrinogen Drugs 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 230000036449 good health Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 230000003340 mental effect Effects 0.000 description 1
- 210000003205 muscle Anatomy 0.000 description 1
- 230000017074 necrotic cell death Effects 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 229910000029 sodium carbonate Inorganic materials 0.000 description 1
- CYHOMWAPJJPNMW-JIGDXULJSA-N tropine Chemical compound C1[C@@H](O)C[C@H]2CC[C@@H]1N2C CYHOMWAPJJPNMW-JIGDXULJSA-N 0.000 description 1
- 238000010792 warming Methods 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F7/10—Cooling bags, e.g. ice-bags
- A61F7/106—Cooling bags, e.g. ice-bags self-cooling, e.g. using a chemical reaction
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B5/00—Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts
- B32B5/22—Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts characterised by the presence of two or more layers which are next to each other and are fibrous, filamentary, formed of particles or foamed
- B32B5/24—Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts characterised by the presence of two or more layers which are next to each other and are fibrous, filamentary, formed of particles or foamed one layer being a fibrous or filamentary layer
- B32B5/26—Layered products characterised by the non- homogeneity or physical structure, i.e. comprising a fibrous, filamentary, particulate or foam layer; Layered products characterised by having a layer differing constitutionally or physically in different parts characterised by the presence of two or more layers which are next to each other and are fibrous, filamentary, formed of particles or foamed one layer being a fibrous or filamentary layer another layer next to it also being fibrous or filamentary
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/00051—Accessories for dressings
- A61F13/00063—Accessories for dressings comprising medicaments or additives, e.g. odor control, PH control, debriding, antimicrobic
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B37/00—Methods or apparatus for laminating, e.g. by curing or by ultrasonic bonding
- B32B37/08—Methods or apparatus for laminating, e.g. by curing or by ultrasonic bonding characterised by the cooling method
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/53—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the absorbing medium
- A61F13/534—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the absorbing medium having an inhomogeneous composition through the thickness of the pad
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/84—Accessories, not otherwise provided for, for absorbent pads
- A61F13/8405—Additives, e.g. for odour, disinfectant or pH control
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F7/00—Heating or cooling appliances for medical or therapeutic treatment of the human body
- A61F2007/0001—Body part
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00089—Wound bandages
- A61F2013/00187—Wound bandages insulating; warmth or cold applying
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F2013/00361—Plasters
- A61F2013/00365—Plasters use
- A61F2013/00463—Plasters use haemostatic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/51—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the outer layers of the pads
- A61F13/514—Backsheet, i.e. the impermeable cover or layer furthest from the skin
- A61F13/51474—Backsheet, i.e. the impermeable cover or layer furthest from the skin characterised by its structure
- A61F2013/51486—Backsheet, i.e. the impermeable cover or layer furthest from the skin characterised by its structure with specially shaped backsheets
- A61F2013/51492—Backsheet, i.e. the impermeable cover or layer furthest from the skin characterised by its structure with specially shaped backsheets having specially shaped gas or air bubbles or bag-like structure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/53—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the absorbing medium
- A61F2013/530131—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the absorbing medium being made in fibre but being not pulp
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61F—FILTERS IMPLANTABLE INTO BLOOD VESSELS; PROSTHESES; DEVICES PROVIDING PATENCY TO, OR PREVENTING COLLAPSING OF, TUBULAR STRUCTURES OF THE BODY, e.g. STENTS; ORTHOPAEDIC, NURSING OR CONTRACEPTIVE DEVICES; FOMENTATION; TREATMENT OR PROTECTION OF EYES OR EARS; BANDAGES, DRESSINGS OR ABSORBENT PADS; FIRST-AID KITS
- A61F13/00—Bandages or dressings; Absorbent pads
- A61F13/15—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators
- A61F13/53—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the absorbing medium
- A61F13/534—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the absorbing medium having an inhomogeneous composition through the thickness of the pad
- A61F2013/53445—Absorbent pads, e.g. sanitary towels, swabs or tampons for external or internal application to the body; Supporting or fastening means therefor; Tampon applicators characterised by the absorbing medium having an inhomogeneous composition through the thickness of the pad from several sheets
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B32—LAYERED PRODUCTS
- B32B—LAYERED PRODUCTS, i.e. PRODUCTS BUILT-UP OF STRATA OF FLAT OR NON-FLAT, e.g. CELLULAR OR HONEYCOMB, FORM
- B32B2262/00—Composition or structural features of fibres which form a fibrous or filamentary layer or are present as additives
- B32B2262/06—Vegetal fibres
- B32B2262/062—Cellulose fibres, e.g. cotton
Landscapes
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Thermal Sciences (AREA)
- Physics & Mathematics (AREA)
- Medicinal Chemistry (AREA)
- Thermotherapy And Cooling Therapy Devices (AREA)
Abstract
A pulp fiber structure of the invention comprises two plies 1, 3 of pulp fibers obtained by crashing wood pulp in pieces, one of these plies 3 is treated by wetting, pressing and drying one surface to form a skin layer 2 on the ply, the two plies are put together to form a composite structure in such a manner that the skin layer 2 is sandwiched between the two plies 1, 3. A haemostatic agent 4 or a freezing mixture is placed on the skin layer 2 before the two plies are put together to provide a staunching or cooling means. <IMAGE>
Description
SPECIFICATION
Pulp fiber structure Backgroundof the invention This invention is directed to a pulp fiber structure, and more particularly to a pulp fiber structure means for stanching or cooling purpose, said means comprising two piles of pulp fibers, the surface of one of which is treated to present a hardened skin layer on which is placed hemostatic agent or freezing mixture, these piles are combined or put together to form one structure with the skin layer continuous to remaining pile of pulp fibers placed in the middle as if sandwiched between two piles of pulp fibers.
More specifically, the invention concerns an emergency stanching means which can be placed on a wound to absorb in its own structure the flow of blood from the wound, to enable said absorbed blood to turn to a clot and then to a scab or crust which will cover the wound to stop further bleeding.
It is needless to say that treatment by a specialist is required when the flow of blood from a wound is substantial, and the wounded person may succumb to a wound due to the delay in receiving a proper treatment.
In recent years, serious injuries are seen frequently at the factories and work cities as well as in traffic accidents. On the other hand, once a severe earthquake breaks out, it is estimated that many persons will be killed or injured in big cities due to tearing down of buildings with fixtures, furniture, glasses, walls and the like broken and falling down. Telephone system for emergency calls and the road traffic would be paralysed, and the injured people cannot expect to be treated at places where they are wounded. A main object of the emergency treatment at the time and place of the injury is to hold down by stopping the flow of blood from a wound to the minimum.Bandage, antiseptic gauze, adhesive plaster and the like are used to cover the wound, but where there is a quantity of blood flow from the wound, these are of little use, and a tourniquet or a piece of cloth cut in a triangularform must be used instead to stop the bleeding. However, if a tourniquet is applied by a person unskilled in the art, nerve and/or muscle may be seriously damaged. If the flow of blood is blocked by binding an arm, for example, for more than an hour, there may be damage to the periphery, and necrosis is likely to occur as a result.
Therefore, where a person is wounded resulting in substantial flow of blood, it is desired that he has an access to a stanching means which can readily be placed on the wound without any danger of inviting any one of the abovedescribed fatal effects.
The invention concerns further a cooling means which can be placed on the wounded part of the body of a person when he receives damage such as sprain or blow from without for the purpose of suppressing swelling or extravasation before the damage becomes too difficult to be cured or causes aftereffects.
Sports are popular nowadays for the purpose of building a strong body, maintaining good health, preventing diseases or for recreation. People, young and old, play to cut down or gain weight, orto relieve mental stress. These amateurs are inferior to the pefessionals in their health, strength and skill, so that they must be careful in selecting a proper game.
In addition, they should consult the doctor in advance, and pay attention to warm up their body before playing. However, many people neglect the above and play in a manner that is not proper, getting sprain or blow as a result.
Sports statistics in Japan show that cases of sprain are 33.6%, and those of blows 14.6%, of all the external injuries sustained in playing. On the other hand, grade school and junior high school children are 21%, senior high school students 31%, and housewives 48%, of all the players. Further, sprains and blows are 20 to 30% of all the injuries in each game.
With regard to the younger people, they receive injuries because, in spite of the fact that they are still weak in their physique, they do not play the right game properly. As to those who are in the middle and old age groups, their body is injured because they neglect day to day exercises as well as warming up and do not to play properly.
Injuries come unexpectedly where there are not doctors or where no adequate facilities for treatment are provided. To make it worse, sprain or blow is taken lightly regardless its graveness and left without being taken care of. As a result, it takes a long time to cure the injury completely. Or, the damaged part may be deformed and the aftereffect may ensue causing inconveniences in daily life.
When a part of the human body is sprained or receives a blow, it is a matter of principle in sports medicine to soak said part in iced water or the place an ice bag filled with ice on said part. However, people seldom prepare ice water before playing. Ice is not always available where such injury is sustained. Treatment which is carried out after the injured part has swollen is not very effective. And thus, a cooling means which can easily be stored or carried and which can expeditiously applied to the injured part has long been wanted.
Summary of the invention
In view of the fact that conventional bandage, gauze or adhesive plaster has no effect in stanching the flow of blood from a wound, it is an object of the invention to offer a pulp fiber structure that can be used as a stanching means to cover a wound which causes substantial flow of blood, said means being so prepared that any person unskilled in medicine can easily apply it on the wound to stop the flow of blood without any need of other stanching means.
Such an object is accomplished according to the invention by offering an emergency stanching means which comprises two piles of pulp fibers formed by crashing wood pulps in pieces, a first pile consisting pulp fibers piled up in one layer, and a second pile also consisting pulp fibers piled up in one layer but with its one surface treated by first moistening with water, pressing said surface and then drying the same, to form a skin layer, said skin layer being continuous to remaining pile of the pulp fibers not so treated, these piles being put together to provide one structure such that said treated surface or skin layer on which hemostatic agent has been placed is located in the middle where these piles join, these piles being finally packed in one piece by means of suitable cover means.
It is another object of the invention to offer, in view of the lack of suitable emergency cooling means to be applied to a part of the body that is sprained or hit, a cooling means that can be easily stored or carried and which can be readily applied to the injured part of the body to effect chilling of said part.
According to the invention, said object can be accomplished by offering a cooling means comprising two piles of pulp fibers obtained by crashing wood pulps in pieces, a first pile consisting pulp fibers piled in one layer, and a second pile consisting also pulp fibers piles up on one layer but with its one surface treated by first moistening with water, pressing said surface and then drying the same to form a skin layer, said skin layer being continuous to the remaining the pulp fibers not so treated, these piles being put together such that said treated skin layer on which suitable freezing mixture has been placed is located in the middle where these piles join, these piles being finally packed in one piece by means of suitable cover means. In use, the package is broken, and water is added to said pile to bring about the cooling effect, and the means is used like a wet compress.
The above and further objects and novel features of the invention will appear more fully from the following detailed description when read in conjunction with accompanying drawings, It is to be expressly understood, however, that the drawings are not intended as a definition of the invention but are for the purpose of illustration only.
Brief description of the drawings
In the drawings:
Figure 1 is a cross-sectional view of a stanching means according to the invention,
Figure 2 is a view similar to that of Figure 1, illustrating the coagulation of blood,
Figure 3 is a cross-sectional view of a cooling means according to the invention,
Figure 4 is a view similar to that of Figure 3, illustrating how added water is absorbed and retained by the structure of the cooling means, and
Figure 5 is a graphic diagram illustrating the change of temperature of the cooling means relative to the lapse of time.
Description of the preferred embodiment
It may be useful to explain the features of pulp fiber pile and its effect to stop the flow of blood before fully describing a preferred embodiment of the invention.
Where a pile of pulp fibers is formed, the pile does not exhibit effective capillary action. Thus, liquid (blood in case of the present invention) absorbed by the pile is retained only at or near where the pile is in contact with sid liquid, and liquid is not dispersed or spread out to surrounding dry portions of the pile. If the pile keeps contact with liquid further, only one part of the pile will be saturated with said liquid.
When blood flows from a wound, as is generally known, fibrinogen in blood plasma turns to insoluble fibrin which tends to confine blood corpuscles, making blood viscous. Blood then turns to clot which in turn changes to scab or crust which stops the flow of blood.
Blood consists 55% blood plasma and 45% corpuscles. That which brings about coagulation of blood is fibrin in blood plasma and corpuscles, and serum has nothing to do with coagulation of blood. When a large quantity of blood flows from a wound, the amount of serum increases at a rate larger than the increase of fibrin, and this increase of serum hinders checking of bleeding. In other words, serum obstructs coagulation of blood. With this basic understanding, an embodiment of the invention will now be described, reference being made to the accompanying drawings.
There is shown in Figure 1 in cross-section a stanching means according to the invention, the means comprising a first pile of pulp fibers and a second pile of pulp fibers which is formed with a skin layer continuous to the remaining pulp fibers in the interior, with pulverized hemostatic agent placed in the middle where these two piles join.
In Figure 1, reference numeral 1 denotes a first pile of pulp fibers, 2 a skin layer, 3 a second pile of pulp fibers having the skin layer 2, 4 pulverized hemostatic agent, 8 an exterior cover. The first pulp fiber pile 1 and the second pulp fiber pile 3 having the skin layer 2 are put together with hemostatic agent 4 sandwiched therebetween. An adhesive tape or cloth, not shown, is placed on the lower cover 8 before the stanching means is marketed.
Figure 2 shows in cross-section the following process: blood is locally absorbed, next saturated, then makes contact with the hemostatic agent placed in the middle of the stanching meas, then tends to coagulate, and further, serum in blood permeates into the skin layer 2 and dispersed in said skin layer 2, with coagulation synergically accelerated in the above process to form a clot which then turns to a scab or crust. In this Figure 2, an area 5 enclosed by a dotted line shows the part that is saturated with blood (the part will be referred to as saturated part hereafter), area 5' a blood clot, and a shaded part 6 a scab, an area enclosed by a chain line a part wherein serum dispersed. In use, the upper cover 8 of Figure 1 makes contact with a wound.
Referring again to Figure 2, when the stanching means of Figure 1 is applied to a wound, blood flowing through the cover 8 is locally absorbed by the first pulp fiber pile 1. In said pulp fiber pile, there will be no permeation or spreading out of blood to the unwetted part of the pile. Thus, if absorption of blood continues, saturated part 5 is formed locally, then blood makes contact with the hemostatic agent 4 located in the middle part of the stanching means.
A suitable hemostatic agent to be used in the stanching means shown in Figure 2 is the Japanese
Pharmacopoeia tropine. The saturated part 5 also makes contact with the skin layer 2. The skin layer 2 shows positive capillary action since it has been treated as described before (wetting, pressing and drying), so that serum in the blood is spread out to unwetted portion as illustrated by the reference numeral 7 in Figure 2. Because of this, the amount of serum which obstructs coagulation of blood decreases in the saturated part 5, which helps acceleration of coagulation and formation of the clot 5'.
The blood clot 5' formed to extend from pulp fiber pile 1 to the skin layer 2 is deprived of the remaining serum, and the clot 5' shrinks gradually. Scab 6 is formed at periphery of clot 5', and the flow of blood is stopped when the scab covers the wound.
The stanching means described so far has a simple structure. In use, it is placed on a wounded part, and its sides are fixed by means of adhesive tapes not shown. The flow of blood is halted without using a tourniquet or the like.
Another embodiment of the invention which is a cooling means is shown in cross-section in Figure 3 in which 11 denotes a first pile of pulp fibers, 12 a skin layer, 13 a second pile of pulp fibers having the skin layer 12, 14 freezing mixture and 17 a cover. The first pulp fiber pile 11 and the second pulp fiber pile 13 having the skin layer 12 is put together to sandwich the freezing mixture 14 therebetween. An adhesive tape or cloth, not shown, is placed on the cover 17.
Figure 4 is a cross-sectional view of the cooling means of Figure 3 to illustrate what happens when water is added. Water is added from above the cooling means as seen in Figure 2. Thereafter, the following were observed: water is retained by the first pulp fiber pile 11, then the part of said pile retaining water is saturated with water. (This part will be referred to as the saturated part hereinafter.)
Water in the saturated part then makes contact with the freezing mixture which acts to exert cooling effect after dissolution. Water then permeates into the skin layer spreading out laterally or horizontally as seen in the drawing, making further contacts with freezing mixture successively and consequently bringing about cooling actions of the dissolved agent.In Figure 4, reference numeral 15 represents the part where water is added, area 16 enclosed by a chain line a part where water has spread and caused dissolution of the freezing mixture. In use, water is added to the upper cover as seen in the drawing, and this upper cover makes contact with a part to be cooled.
Referring again to Figure 4, water is absorbed by the pulp fiber pile 11 through the cover 17. Said pulp fiber pile shows little capillary action by itself, so that absorved water is retained locally at or near where it was added without spreading out. When more water is added, this part will be saturated with water.
However, the skin layer 12 of the pulp fiber pile 13 shows positive capillary action due to the treatment given to it, so that water reaching the skin layer is spread out laterally or horizontally.
With the cooling means of Figure 4 having an area of 90 to 100 cm2, for example, suitable amount of water, for example 20 to 30 g, if poured on the cover 17 over the part 15. Apart of the pulp fiber pile 11 becomes saturated with water locally. Water then makes contact with the freezing mixture 14 placed in the middle of the cooling means, dissolve the mixture to bring about a cooling action. Water permeates the skin layer 12 laterally to make further contacts with the freezing mixture 14 successively, causing more cooling actions to enhance the cooling effect of the cooling means.
The freezing mixture described above is a mixture which exhibits cooling effect when dissolved in water. Such mixture can be handled easily, and it is chep. In the described embodiment, sodium carbonate (na2Ct3) and ammonium chloride (NH4Ct) were mixed at a rate of 1:1.5. The cooling effect of such a mixture is shown in Figure 5.
In a graphic representation of Figure 5, the abscissa shows the passage of time from a point when water is added to the cooling means of the invention, the ordinate the temperature of the part of the cooling means in contact with a part of human skin that was injured. When water was added, the temperature of part 15 of the cooling means was 0 C.
When the part 15 is placed on the injured part, the part 15 is warmed by the said part of which temperature would be slightly higher than the vital warmth. As time passes, the temperature of the part 15 goes up as illustrated in Figure 5, showing 80C after lapse of 30 minutes, 12.5 C when one hour lapsed. This would show that the injured part is sufficiently cooled for one hour. As an injured person would be treated by a doctor within one hour from the time he was injured under normal circumstances, Figure 5 shows that an emergency cooling treatment required under the principle of the sports medicine is effectively carried out when the cooling means of the invention is used.
However, if water in excess of 30g is added, more water prmeates and is spread in the skin layer, bringing about more dissolution of the freezing mixture. Although cooling effect is increased, time during which cooling is effective will be shortened accordingly.
As will be understood from the foregoing, the structure according to the invention becomes a cooling means by simply adding water to it. It can then placed on the part of the body sprained or hit, and then can be fixed in position by an adhesive tape, not shown. It will then prevents swelling of the body and extravasation. Its structure is simple, and it can be stored and/or carried handily. It can be applied easily. Because of these, the cooling means of the invention is suitable as an emergency aid. In the foregoing, the invention has been described by reference to people playing, but the means of the invention can also be used in other cases. Where a patient's head must be cooled at a place where there is no ice, the means of the invention can be used instead of an ice bag. Or, it may be used on the body of a pet or a racing horse.
Thus, the invention having been described in its best embodiment and mode of operation, that which is desired to be protected by Letters Patent is:
Claims (6)
1. A pulp fiber structure which comprises a first pile of pulp fibers obtained by crashing wood pulp in pieces and a second pile of pulp fibers of the same kind of which one surface is treated by wetting, pressing and drying to form a skin layer which is continuous to the remaining pile of pulp fibers, said two piles of pulp fibers are put together to form a one piece structure with said skin layer interposed between said piles of pulp fibers.
2. A staunching means according to claim 1 wherein hemostatic agent is placed on said skin layer before said piles are put together.
3. A cooling means according to claim 1 wherein freezing mixture is placed on said skin layer before said piles are put together.
4. A pulp fiber structure substantially as hereinbefore described with reference to and as illustrated in Figures 1 to 5 of the accompanying drawings.
5. A staunching means substantially as hereinbefore described with reference to and as illustrated in
Figures 1 and 2 of the accompanying drawings.
6. A cooling means substantially as hereinbefore described with reference to and as illustrated in
Figures 3 to 5 of the accompanying drawings.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB08211191A GB2118482B (en) | 1982-04-17 | 1982-04-17 | Pulp fiber structure |
HK721/86A HK72186A (en) | 1982-04-17 | 1986-09-25 | A wound staunching means and a cooling means including wood fibre structures |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB08211191A GB2118482B (en) | 1982-04-17 | 1982-04-17 | Pulp fiber structure |
Publications (2)
Publication Number | Publication Date |
---|---|
GB2118482A true GB2118482A (en) | 1983-11-02 |
GB2118482B GB2118482B (en) | 1985-11-27 |
Family
ID=10529756
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
GB08211191A Expired GB2118482B (en) | 1982-04-17 | 1982-04-17 | Pulp fiber structure |
Country Status (2)
Country | Link |
---|---|
GB (1) | GB2118482B (en) |
HK (1) | HK72186A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2647336A1 (en) * | 1989-05-29 | 1990-11-30 | Treviers Sa Laboratoires | Novel dressings having improved absorption, and their applications |
EP1156765A1 (en) * | 1998-11-12 | 2001-11-28 | Polymer Biosciences, Inc. | Hemostatic polymer useful for rapid blood coagulation and hemostasis |
CN112472416A (en) * | 2020-11-24 | 2021-03-12 | 天长市康特美防护用品有限公司 | Disposable blood-sucking armpit pad |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
AU2002361902A1 (en) | 2001-12-31 | 2003-07-24 | Ares Medical, Inc. | Hemostatic compositions and methods for controlling bleeding |
-
1982
- 1982-04-17 GB GB08211191A patent/GB2118482B/en not_active Expired
-
1986
- 1986-09-25 HK HK721/86A patent/HK72186A/en not_active IP Right Cessation
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR2647336A1 (en) * | 1989-05-29 | 1990-11-30 | Treviers Sa Laboratoires | Novel dressings having improved absorption, and their applications |
EP1156765A1 (en) * | 1998-11-12 | 2001-11-28 | Polymer Biosciences, Inc. | Hemostatic polymer useful for rapid blood coagulation and hemostasis |
EP1156765A4 (en) * | 1998-11-12 | 2002-08-07 | Polymer Biosciences Inc | Hemostatic polymer useful for rapid blood coagulation and hemostasis |
CN112472416A (en) * | 2020-11-24 | 2021-03-12 | 天长市康特美防护用品有限公司 | Disposable blood-sucking armpit pad |
Also Published As
Publication number | Publication date |
---|---|
GB2118482B (en) | 1985-11-27 |
HK72186A (en) | 1986-10-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Stover | Air stirrup management of ankle injuries in the athlete | |
US8722081B2 (en) | Hemostatic textile material | |
Hughes et al. | A comparison of ankle taping and a semirigid support | |
US20060029654A1 (en) | Analgesic patch for sports injury rehabilitation medicine and method to alleviate pain | |
US4401113A (en) | Sponge splint compression dressing | |
Killian | Cold and Frost Injuries—Rewarming Damages Biological, Angiological, and Clinical Aspects: Biological, Angiological, and Clinical Aspects | |
GB2118482A (en) | Pulp fiber structure | |
Glenn et al. | The treatment of burns by the closed-plaster method, with certain physiological considerations implicit in the success of this technique | |
LaVelle et al. | Differential conduction of cold through barriers | |
Schlesinger et al. | Use of reston TM Foam in liposuction | |
JP2000154469A (en) | Cold sheet and compress | |
KR860001919B1 (en) | Hemostatic tool | |
US4476115A (en) | Analgesic composition and method of treating subdermal pain | |
JP2795782B2 (en) | Icing material | |
JPS58152558A (en) | Emergency cooler | |
DE29518881U1 (en) | Self-cooling, adhesive compression bandage | |
JPH0323173B2 (en) | ||
Ruf et al. | Surgical technic for treatment of splenic rupture | |
Clough et al. | Athletic Injuries and Their Treatment | |
KR101917268B1 (en) | liquid band for protection or healing of wound | |
GLENN | A Physiologic Analysis of the Nature and of the Treatment of Burns | |
RU2191004C2 (en) | Method for conservative treatment of frostbitten limbs | |
Jaeger | Psoriasis treatment with betamethasone dipropionate using short-term application and short-term occlusion | |
KR900017588A (en) | Synergistic Formulations and Uses As A Therapeutic Agent | |
Ryan | Traumatic injuries: Office treatment of deep bruises |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PCNP | Patent ceased through non-payment of renewal fee |
Effective date: 19980417 |